Ireland
--:--IST
Latest
Clinical Trials in Sweden / NCT07073235
Recruiting Not applicable

Effects of Intermittent Theta Burst Stimulation (iTBS) on Motor Recovery of Lower Extremity in Chronic Stroke Patients

NCT07073235 · tracked via the Priya Life Science Sweden tracker
Phase
Not applicable
Started
2025-11
Last updated
2025-11-25

Condition(s) studied

StrokeHemiparesis After StrokeChronic Stroke PatientsHemiplegiaAmbulatory Difficulty

Investigational drug(s) / intervention(s)

Intermittent Theta Burst StimulationSham Intermittent Theta Burst Stimulation

Intermittent Theta Burst Stimulation: iTBS protocol: 600 pulses at 80% of AMT for 190 sec on the contralesional cerebellum, targeted with the support of a neuronavigational system, 15 sessions over a period of 5 weeks

Sham Intermittent Theta Burst Stimulation: It is identical to its active version, replicates operational sounds, and delivers a very shallow magnetic field to mimic the sensation of magnetic stimulation.

Study summary

This study aims to evaluate the effects and clinical feasibility of non-invasive brain stimulation protocols, specifically intermittent Theta Burst Stimulation, as part of rehabilitation interventions for motor recovery of lower extremity in the chronic phase after stroke.

It also seeks to explore the underlying mechanisms by investigating changes of functional and structural brain networks.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age over 18 * Chronic stroke (\>6 months) * Residual hemiparesis FAC ≥3 Exclusion Criteria: * Metal implants * Epilepsy/seizures * Pregnancy * Claustrophobia (related to MRIs exams) * Severe cognitive impairment * Untreated or unstable depression/anxiety * Other disabilities prohibiting intensive physical training

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Department of Rehabilitation Medicine, Danderyd Hospital, Danderyd, Stockholm 18288 Stockholm Sweden Recruiting

More Danderyd Hospital trials in Sweden

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07073235 on ClinicalTrials.gov ↗ ← All trials in Sweden